Literature DB >> 26784526

Hepatic Primary and Secondary Cholesterol Deposition and Damage in Niemann-Pick Disease.

Marta Bosch1, Alba Fajardo2, Rafael Alcalá-Vida3, Andrea Fernández-Vidal2, Francesc Tebar4, Carlos Enrich4, Francesc Cardellach5, Esther Pérez-Navarro3, Albert Pol6.   

Abstract

Niemann-Pick C disease is a neurovisceral disorder caused by mutations in the NPC gene that result in systemic accumulation of intracellular cholesterol. Although neurodegeneration defines the disease's severity, in most patients it is preceded by hepatic complications such as cholestatic jaundice or hepatomegaly. To analyze the contribution of the hepatic disease in Niemann-Pick C disease progression and to evaluate the degree of primary and secondary hepatic damage, we generated a transgenic mouse with liver-selective expression of NPC1 from embryonic stages. Hepatic NPC1 re-expression did not ameliorate the onset and progression of neurodegeneration of the NPC1-null animal. However, the mice showed reduced hepatomegalia and dramatic, although not complete, reduction of hepatic cholesterol and serum bile salts, bilirubin, and transaminase levels. Therefore, hepatic primary and secondary cholesterol deposition and damage occur simultaneously during Niemann-Pick C disease progression.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26784526     DOI: 10.1016/j.ajpath.2015.12.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  5 in total

Review 1.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

2.  Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.

Authors:  Sandra Torres; Nuria Matías; Anna Baulies; Susana Nuñez; Cristina Alarcon-Vila; Laura Martinez; Natalia Nuño; Anna Fernandez; Joan Caballeria; Thierry Levade; Alba Gonzalez-Franquesa; Pablo Garcia-Rovés; Elisa Balboa; Silvana Zanlungo; Gemma Fabrías; Josefina Casas; Carlos Enrich; Carmen Garcia-Ruiz; José C Fernández-Checa
Journal:  Redox Biol       Date:  2016-11-20       Impact factor: 11.799

3.  Signatures of natural selection and ethnic-specific prevalence of NPC1 pathogenic mutations contributing to obesity and Niemann-Pick disease type C1.

Authors:  Andreea Chiorean; William S Garver; David Meyre
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

Review 4.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

5.  Identification of novel mutations among Iranian NPC1 patients: a bioinformatics approach to predict pathogenic mutations.

Authors:  Rezvan Abtahi; Parvaneh Karimzadeh; Omid Aryani; Diba Akbarzadeh; Shadab Salehpour; Alireza Rezayi; Seyed Hassan Tonekaboni; Reza Zolfaghari Emameh; Massoud Houshmand
Journal:  Hereditas       Date:  2022-01-27       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.